What is the World Federation of Neurological Surgeons (WFNS) grading scale for aneurysmal subarachnoid hemorrhage and how does it guide treatment decisions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

WFNS Score

The World Federation of Neurological Surgeons (WFNS) grading scale is a Class I, Level B-NR recommended clinical tool for determining initial severity and predicting outcome in aneurysmal subarachnoid hemorrhage (aSAH), with grades 4-5 defining high-grade SAH that requires individualized treatment decisions based on presence of irrecoverable brain injury 1.

What the WFNS Scale Is

The WFNS scale is a clinical grading system that stratifies aSAH patients from Grade I (best) to Grade V (worst) based on:

  • Glasgow Coma Scale (GCS) score
  • Presence or absence of motor deficits

This scale serves as both a prognostic indicator and a standardization tool for hemorrhage severity 1.

Clinical Significance and Outcome Prediction

High-grade SAH is defined as WFNS Grade 4-5, which carries significant mortality and morbidity risk. However, outcomes are not uniformly poor:

  • Approximately 39-40% of treated high-grade patients achieve good outcomes at 12 months 1
  • The scale's predictive accuracy varies significantly based on timing of assessment

Critical Timing Considerations

The WFNS grade assessed at 48 hours post-aneurysm occlusion provides superior prognostic accuracy compared to admission grading 2:

  • 48-hour assessment achieves AUC of 0.817-0.845 for discharge outcomes
  • This timing reflects stabilized neurological status after resolution of confounding factors
  • Admission grading may misclassify "false poor grade" patients who improve within days

The worst pretreatment WFNS grade is the single best predictor when early assessment is required 3. Patients with GCS 13 have substantially worse outcomes than those with GCS 14, supporting the modified WFNS scale that separates these groups 4.

Treatment Decision Algorithm

For WFNS Grade 1-3 (Low-to-Moderate Grade):

  • Proceed with aneurysm treatment (endovascular coiling or surgical clipping) to prevent rebleeding
  • Management in specialized neuro-ICU with multidisciplinary teams 1

For WFNS Grade 4-5 (High-Grade):

Assess for irrecoverable brain injury markers 1:

  • Absent or partially absent brainstem reflexes (especially if persistent at 12-24 hours)
  • Lack of purposeful response to noxious stimuli
  • Large completed ischemic infarct on admission CT
  • Global cerebral edema consistent with anoxic injury

If irrecoverable injury present: Aneurysm treatment provides no benefit; focus on comfort measures

If NO irrecoverable injury:

  1. Identify and correct modifiable conditions first:

    • Seizures or status epilepticus
    • Hydrocephalus requiring drainage
    • Severe electrolyte abnormalities (hyponatremia)
    • Hypothermia
  2. Reassess WFNS grade after correction - many "false poor grade" patients improve 5, 6

  3. Consider aneurysm treatment with shared decision-making involving family/surrogates 1

  4. Factor in age: Patients >65 years have lower functional independence rates (42% vs 82% in younger patients at 6 years), but treatment remains reasonable after family discussion 1

Key Pitfalls to Avoid

  • Don't grade too early: Admission WFNS may misclassify patients due to sedation, intubation, or reversible factors 2, 5
  • Don't assume all Grade 4-5 patients have poor prognosis: 40% achieve favorable outcomes with treatment 1
  • Don't miss modifiable causes of poor grade: Hydrocephalus, seizures, and metabolic derangements can falsely elevate the grade 1, 6
  • Don't use timing of grading inconsistently: Standardize whether using admission, worst pretreatment, or 48-hour post-treatment assessment 3

Practical Application

For prognostication: Use 48-hour post-occlusion WFNS grade when possible for most accurate outcome prediction 2

For acute treatment decisions: Use worst pretreatment WFNS grade, but reassess after correcting modifiable factors 3, 6

For research/quality metrics: Specify timing of WFNS assessment, as this significantly impacts interpretation 2, 3

The WFNS scale remains superior to Hunt-Hess for outcome prediction when properly timed, and outperforms composite scores for clinical decision-making in most scenarios 3, 7.

Related Questions

What is the Ogilvy‑Carter grading system used for in aneurysmal subarachnoid hemorrhage?
What are the grades of the Hunt and Hess scale for aneurysmal subarachnoid hemorrhage and the associated management and prognosis?
What are the Hunt-Hess grades and World Federation of Neurological Surgeons (WFNS) grades for a ruptured cerebral aneurysm?
What is the recommended treatment for subarachnoid hemorrhage?
Do intracranial (brain) aneurysms have a genetic basis?
What are the diagnostic criteria for eosinophilic colitis?
What are the grades of the Hunt and Hess scale for aneurysmal subarachnoid hemorrhage and the associated management and prognosis?
In a 70-year-old man with severe blunt trauma, massive transfusion, and recent antiplatelet therapy, what is the risk of complications from his hepatic, pancreatic, and renal contusions?
What is the appropriate post‑operative treatment and surveillance strategy for a patient with stage IB hepatocellular carcinoma (solitary tumor 2–5 cm) after curative hepatectomy?
How should I manage a patient with a resolved parasitic infection (treated with albendazole), hyperuricemia (uric acid 9.8 mg/dL), prediabetes on metformin extended‑release, non‑alcoholic fatty liver disease on loveprem, a history of kidney stones on febuxostat, and elevated ferritin (586 µg/L) with low MCV and MCH but normal MCHC and hemoglobin 129 g/L?
For a patient with hepatic contusion, possible pancreatic injury, and renal contusion who is on recent antiplatelet therapy, what monitoring strategy should be used, how should changes in risk be assessed, and after how many days post‑injury can the patient consider himself improving?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.